The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to ...

Geneos Wealth Management Inc. lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.6% in the ...

Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.

DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 ...

In the Spring 2024 semester, Glucoguard was invited to participate in the MADO program through our ongoing relationship with ...

DXCM's top line reflects strong demand for its CGM sensors. International expansion is also driving sales higher. Gross margin reflects inventory damage.

Baillie Gifford's 13F portfolio shows changes in top holdings like Amazon and NVIDIA, with increased stakes in SEA Ltd. Read ...